Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Reconciliation of cash and cash equivalents and restricted cash presented on the consolidated statements of cash flows
Cash and cash equivalents	$ 29,619	[1]	$ 56,948	[1]	$ 22,704
Restricted cash	8,897	[1]	39,519	[1]	24,078
Total cash and cash equivalents and restricted cash	38,516		96,467		46,782
Supplemental disclosure of cash flow information:
Cash paid for interest	59,034		48,772		22,878
Supplemental disclosure of non-cash investing and financing activity:
Origination of sales-type lease					10,194
Acquisition of real estate			157
Assumption of other liabilities/debt obligations			157		10,194
Investor Unit conversion (refer to Note 11)					250,000
Dividends declared to common shareholders	9,647		8,636		7,478
Accrued finance costs	89		8		658
Accrued offering costs	50		$ 47		$ 250
Caret Unit conversion (refers to Note 11)	$ 747

[1] Refer to Note 2 for details on the Company’s consolidated variable interest entities ("VIEs").